The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy

Avaí Bio, Inc. (OTCQB: AVAI) and partner Austrianova announced on May 20, 2026 completion of a GMP Master Cell Bank of genetically modified cells overexpressing alpha-Klotho for use in an encapsulated cell therapy targeting age-related diseases. The MCB will undergo third-party testing for viral and microbial contamination before advancing to Working Cell Bank and clinical product manufacturing.